Wing Yu Leung

Wing Yu Leung is the founder of Biomedic Holdings Ltd., founded in 2004.
Current jobs include Director at Pacific Advantage (International) Ltd., Independent Director at Zai Lab Ltd. since 2020, Director at dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. since 2016, Director at Zhejiang Nurotron Nerve Electronic Technology Co Ltd since 2014, Director at New Horizon Health Sciences Co. Ltd. since 2018, Director at Nurotron Biotechnology, Inc., Director at Beijing Shenogen Pharma Group Ltd., Partner at Qiming Development Hk Ltd. since 2007, Managing Partner at Qiming Venture Partners Ltd. since 2009, and Managing Partner at Aulis Capital.
Former jobs include Vice Chairman at Venus Medtech (Hangzhou), Inc. from 2013 to 2022, Director at Goodwill E-Health Info Co., Ltd., Director at Sangon Biotech (Shanghai) Co., Ltd., Director at Gan & Lee Pharmaceuticals Co., Ltd. from 2010 to 2021, Director at Berry Genomics Co., Ltd. from 2013 to 2017, Director at Fujian Herui Gene Technology Co., Ltd., Non-Executive Director at New Horizon Health Ltd. from 2020 to 2022, Director at Berry Oncology Co. Ltd., Non-Executive Director at CanSino Biologics, Inc. from 2015 to 2024, Independent Non-Executive Director at Hong Kong Exchanges & Clearing Ltd. from 2021 to 2025, Venture Partner at PacRim Venture Partners, Partner at PacRim Venture Partners from 2001 to 2003, and Principal at MFVC, Inc. Education includes an MBA from Stanford University and Stanford Graduate School of Business conferred in 2001, and undergraduate degrees from Cornell University in 1992 and the University of Illinois.